Table 1.
Seronegative Control | ||
---|---|---|
S/N* | Race | Age |
F1 | Asian/Pacific | 45 |
F2 | Black | 23 |
F3 | Black | 66 |
F4 | Black | 17 |
F5 | Black | 51 |
F6 | Black | 40 |
F7 | Black | 50 |
F8 | Black | 42 |
F9 | Black | 65 |
F10 | Black | 52 |
F11 | Black | 46 |
M1 | Other | 29 |
M2 | Black | 69 |
M3 | Black | 62 |
M4 | Black | 24 |
M5 | Black | 28 |
M6 | Black | 47 |
Asymptomatic carriers | ||
S/N | Race | Age |
F1 | Black | 57 |
F2 | Black | 19 |
F3 | Black | 23 |
F4 | Black | 40 |
F5 | Black | 62 |
F6 | Black | 43 |
F7 | Black | 40 |
F8 | Black | 42 |
F9 | Black | 40 |
F10 | Black | 46 |
F11 | Black | 49 |
M1 | Black | 73 |
M2 | Black | 45 |
M3 | Black | 30 |
M4 | Black | 19 |
M5 | Black | 13 |
M6 | Black | 63 |
ATL patients | ||
S/N | Race | Age |
F1 | Black | 48 |
F2 | Black | 49 |
F3 | Black | 53 |
F4 | Black | 68 |
F5 | Black | 49 |
F6 | Black | 68 |
F7 | Black | 41 |
F8 | Black | 27 |
F9 | Black | 20 |
F10 | Black | 51 |
F11 | Black | 41 |
M1 | Black | 30 |
M2 | Black | 57 |
M3 | Black | 22 |
M4 | Other | 25 |
M5 | Other | 46 |
M6 | Other | 75 |
HAM/TSP patients | ||
S/N | Race | Age |
F1 | Black | 41 |
F2 | Black | 23 |
F3 | Black | 49 |
F4 | Black | 42 |
F5 | Black/White | 51 |
F6 | Black | 19 |
F7 | Black | 47 |
F8 | Black | 64 |
F9 | Black | 49 |
F10 | Black | 63 |
M1 | Black | 16 |
M2 | Black | 22 |
M3 | Black | 75 |
M4 | Black | 46 |
M5 | Black | 57 |
M6 | Black | 31 |
M7 | Black | 57 |
F stands for female, M for male